The idea that many principal investigators (PIs) only participate in one clinical trial before leaving has been debated for years. But what does the data actually show? And should the industry be worried? Join Advarra's Elisa Cascade alongside fellow experts from SCRS, Tufts Center for the Study of Drug Development, Clinical Trials Transformation Initiative (CTTI), Continuum Clinical, A Spectrum Science Company, and Clinical Leader, as they break down the research, share insights, and discuss potential solutions in this upcoming webinar. Don’t miss this data-driven conversation on a critical issue in clinical research. Register here: https://lnkd.in/g9q3PBvH
